206 related articles for article (PubMed ID: 32388925)
1. Head-to-head comparison of cerebral blood flow single-photon emission computed tomography and
Nadebaum DP; Krishnadas N; Poon AMT; Kalff V; Lichtenstein M; Villemagne VL; Jones G; Rowe CC
Intern Med J; 2021 Aug; 51(8):1243-1250. PubMed ID: 32388925
[TBL] [Abstract][Full Text] [Related]
2. The Cingulate Island Sign on FDG-PET vs. IMP-SPECT to Assess Mild Cognitive Impairment in Alzheimer's Disease vs. Dementia with Lewy Bodies.
Chiba Y; Fujishiro H; Iseki E; Kasanuki K; Sato K
J Neuroimaging; 2019 Nov; 29(6):712-720. PubMed ID: 31199036
[TBL] [Abstract][Full Text] [Related]
3. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
[TBL] [Abstract][Full Text] [Related]
4. The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies.
Lim SM; Katsifis A; Villemagne VL; Best R; Jones G; Saling M; Bradshaw J; Merory J; Woodward M; Hopwood M; Rowe CC
J Nucl Med; 2009 Oct; 50(10):1638-45. PubMed ID: 19759102
[TBL] [Abstract][Full Text] [Related]
5. Direct comparison study between FDG-PET and IMP-SPECT for diagnosing Alzheimer's disease using 3D-SSP analysis in the same patients.
Nihashi T; Yatsuya H; Hayasaka K; Kato R; Kawatsu S; Arahata Y; Iwai K; Takeda A; Washimi Y; Yoshimura K; Mizuno K; Kato T; Naganawa S; Ito K
Radiat Med; 2007 Jul; 25(6):255-62. PubMed ID: 17634878
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the diagnostic sensitivity of MRI, CBF-SPECT, FDG-PET and cerebrospinal fluid biomarkers for detecting Alzheimer's disease in a memory clinic.
Morinaga A; Ono K; Ikeda T; Ikeda Y; Shima K; Noguchi-Shinohara M; Samuraki M; Yanase D; Yoshita M; Iwasa K; Mastunari I; Yamada M
Dement Geriatr Cogn Disord; 2010; 30(4):285-92. PubMed ID: 20861634
[TBL] [Abstract][Full Text] [Related]
7. Arterial spin labeling versus
Dolui S; Li Z; Nasrallah IM; Detre JA; Wolk DA
Neuroimage Clin; 2020; 25():102146. PubMed ID: 31931403
[TBL] [Abstract][Full Text] [Related]
8. Post-carotid endarterectomy changes in cerebral glucose metabolism on (18)F-fluorodeoxyglucose positron emission tomography associated with postoperative improvement or impairment in cognitive function.
Yoshida K; Ogasawara K; Saura H; Saito H; Kobayashi M; Yoshida K; Terasaki K; Fujiwara S; Ogawa A
J Neurosurg; 2015 Dec; 123(6):1546-54. PubMed ID: 26230467
[TBL] [Abstract][Full Text] [Related]
9. Early differential diagnosis between Alzheimer's disease and dementia with Lewy bodies: Comparison between (18)F-FDG PET and (123)I-IMP SPECT.
Chiba Y; Iseki E; Fujishiro H; Ota K; Kasanuki K; Suzuki M; Hirayasu Y; Arai H; Sato K
Psychiatry Res Neuroimaging; 2016 Mar; 249():105-12. PubMed ID: 26857415
[TBL] [Abstract][Full Text] [Related]
10. 18F-FDG PET and perfusion SPECT in the diagnosis of Alzheimer and Lewy body dementias.
O'Brien JT; Firbank MJ; Davison C; Barnett N; Bamford C; Donaldson C; Olsen K; Herholz K; Williams D; Lloyd J
J Nucl Med; 2014 Dec; 55(12):1959-65. PubMed ID: 25453043
[TBL] [Abstract][Full Text] [Related]
11. Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria.
Ito K; Shimano Y; Imabayashi E; Nakata Y; Omachi Y; Sato N; Arima K; Matsuda H
Int J Geriatr Psychiatry; 2014 Oct; 29(10):1079-86. PubMed ID: 24687634
[TBL] [Abstract][Full Text] [Related]
12. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
Tosun D; Schuff N; Jagust W; Weiner MW;
Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
[TBL] [Abstract][Full Text] [Related]
13. Support vector machine-based classification of neuroimages in Alzheimer's disease: direct comparison of FDG-PET, rCBF-SPECT and MRI data acquired from the same individuals.
Ferreira LK; Rondina JM; Kubo R; Ono CR; Leite CC; Smid J; Bottino C; Nitrini R; Busatto GF; Duran FL; Buchpiguel CA
Braz J Psychiatry; 2018; 40(2):181-191. PubMed ID: 28977066
[TBL] [Abstract][Full Text] [Related]
14. Summary metrics to assess Alzheimer disease-related hypometabolic pattern with 18F-FDG PET: head-to-head comparison.
Caroli A; Prestia A; Chen K; Ayutyanont N; Landau SM; Madison CM; Haense C; Herholz K; Nobili F; Reiman EM; Jagust WJ; Frisoni GB;
J Nucl Med; 2012 Apr; 53(4):592-600. PubMed ID: 22343502
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of early-phase [
Daerr S; Brendel M; Zach C; Mille E; Schilling D; Zacherl MJ; Bürger K; Danek A; Pogarell O; Schildan A; Patt M; Barthel H; Sabri O; Bartenstein P; Rominger A
Neuroimage Clin; 2017; 14():77-86. PubMed ID: 28138429
[TBL] [Abstract][Full Text] [Related]
16. Serial changes in glucose-loaded 18F-fluoro-2-deoxyglucose positron emission tomography, 99mTc-tetrofosmin and 123I-beta-methyl-p-iodophenyl-penta-decanoic acid myocardial single-photon emission computed tomography images in patients with anterior acute myocardial infarction.
Fukuoka R; Horita Y; Namura M; Ikeda M; Terai H; Tama N; Takagi T; Bunko H
Circ J; 2013; 77(1):137-45. PubMed ID: 23037521
[TBL] [Abstract][Full Text] [Related]
17. Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment.
Grimmer T; Wutz C; Alexopoulos P; Drzezga A; Förster S; Förstl H; Goldhardt O; Ortner M; Sorg C; Kurz A
J Nucl Med; 2016 Feb; 57(2):204-7. PubMed ID: 26585056
[TBL] [Abstract][Full Text] [Related]
18. Practical assessment of myocardial viability with a positron coincidence gamma camera using 18F-fluorodeoxyglucose in acute myocardial infarction: comparison with dedicated positron emission tomography and 201Tl single photon emission computed tomography.
Seki R; Seki H; Toyama T; Koyama K; Endo K; Kurabayashi M
J Cardiol; 2009 Apr; 53(2):265-71. PubMed ID: 19304132
[TBL] [Abstract][Full Text] [Related]
19. Comparing 18-fluoro-2-deoxyglucose positron emission tomography with a combination of technetium 99m tetrofosmin single photon emission computed tomography and computed tomography to detect recurrent or persistent nasopharyngeal carcinomas after radiotherapy.
Kao CH; Tsai SC; Wang JJ; Ho YJ; Yen RF; Ho ST
Cancer; 2001 Jul; 92(2):434-9. PubMed ID: 11466699
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact and diagnostic accuracy of 2-[
Motara H; Olusoga T; Russell G; Jamieson S; Ahmed S; Brindle N; Pillai A; Scarsbrook AF; Patel CN; Chowdhury FU
Clin Radiol; 2017 Jan; 72(1):63-73. PubMed ID: 27637430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
